Table Info

Table 1.

Main characteristics of the patients with pyogenic liver abscesses (PLAs)

Characteristics	Cases
No. patients	36
No. PLAs	39
Mean size (cm, ± SD)	7.6 ± 3.4
Site right/left	27/12
Single/multiple^*	30/6
Etiology
Neoplasia colon/pancreas/biliary tract	2/4/6
Choledocholithiasis	6
Post-surgery	7
Idiopathic	5
Diabetes	3
Diverticulitis	2
Foreign body	1

^* Per patient

Declarations

Author contributions

GF: Conceptualization, Investigation, Writing—original draft, Writing—review & editing, Validation. The author read and approved the submitted version.

Conflicts of interest

The author declares that there are no conflicts of interest.

Ethical approval

The present study “Clinical utility of combined contrast-enhanced ultrasound and intracavitary contrast-enhanced ultrasound in the percutaneous treatment of pyogenic liver abscess” was approved by the Pineta Grande Ethics Committee, protocol number 123/2022.

Consent to participate

Informed consent to participate in the study was obtained from all participants.

Consent to publication

Patients gave their consent to publication of images of their examinations.

Availability of data and materials

The datasets [clinical records and imaging] for this study can be requested to archivio@pinetagrande.it.

Funding

Not applicable.

Copyright

References

Burrowes DP, Kono Y, Medellin A, Wilson SR. RadioGraphics Update: Contrast-enhanced US Approach to the Diagnosis of Focal Liver Masses. Radiographics. 2020;40:E16–20. [DOI] [PubMed]

Dietrich CF, Nolsøe CP, Barr RG, Berzigotti A, Burns PN, Cantisani V, et al. Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver-Update 2020-WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. Ultraschall Med. 2020;41:562–85. [DOI] [PubMed]

Nolsøe CP, Nolsøe AB, Klubien J, Pommergaard H, Rosenberg J, Meloni MF, et al. Use of Ultrasound Contrast Agents in Relation to Percutaneous Interventional Procedures: A Systematic Review and Pictorial Essay. J Ultrasound Med. 2018;37:1305–24. [DOI] [PubMed]

Huang DY, Yusuf GT, Daneshi M, Ramnarine R, Deganello A, Sellars ME, et al. Contrast-enhanced ultrasound (CEUS) in abdominal intervention. Abdom Radiol (NY). 2018;43:960–76. [DOI] [PubMed] [PMC]

Huang DY, Yusuf GT, Daneshi M, Husainy MA, Ramnarine R, Sellars MEK, et al. Contrast-enhanced US-guided Interventions: Improving Success Rate and Avoiding Complications Using US Contrast Agents. Radiographics. 2017;37:652–64. [DOI] [PubMed]

Pepin EW, Nordeck SM, Fetzer DT. Nontraditional Uses of US Contrast Agents in Abdominal Imaging and Intervention. Radiographics. 2022;42:1724–41. [DOI] [PubMed]

Russell G, Strnad BS, Ludwig DR, Middleton WD, Itani M, Khot R, et al. Contrast-Enhanced Ultrasound for Image-Guided Procedures. Tech Vasc Interv Radiol. 2023;26:100913. [DOI] [PubMed]

Heinzmann A, Müller T, Leitlein J, Braun B, Kubicka S, Blank W. Endocavitary contrast enhanced ultrasound (CEUS)—work in progress. Ultraschall Med. 2012;33:76–84. [DOI] [PubMed]

Müller T, Blank W, Leitlein J, Kubicka S, Heinzmann A. Endocavitary contrast-enhanced ultrasound: a technique whose time has come? J Clin Ultrasound. 2015;43:71–80. [DOI] [PubMed]

10.

Ignee A, Jenssen C, Cui X, Schuessler G, Dietrich CF. Intracavitary contrast-enhanced ultrasound in abscess drainage—feasibility and clinical value. Scand J Gastroenterol. 2016;51:41–7. [DOI] [PubMed]

11.

Yusuf GT, Fang C, Huang DY, Sellars ME, Deganello A, Sidhu PS. Endocavitary contrast enhanced ultrasound (CEUS): a novel problem solving technique. Insights Imaging. 2018;9:303–11. [DOI] [PubMed] [PMC]

12.

Francica G. Intracavitary contrast-enhanced ultrasound in ultrasound-guided percutaneous management of abdominal fluid collections/abscesses by a single clinician: an example of point-of-care ultrasound. J Ultrasound. 2020;23:175–81. [DOI] [PubMed] [PMC]

13.

Francica G, Meloni MF, de Sio I, Terracciano F, Caturelli E, Riccardi L, et al. Biopsy of Liver Target Lesions under Contrast-Enhanced Ultrasound Guidance - A Multi-Center Study. Ultraschall Med. 2018;39:448–53. [DOI] [PubMed] [PMC]

14.

Meloni MF, Francica G, Eisenbrey J. CEUS in treatment response evaluation: RFA, microwave. In: Lyshchik A, editor. Specialty imaging: fundamentals of CEUS. 1st ed. Amsterdam: Elsevier; 2019. pp. 322–7.

15.

Francica G, Meloni MF, Riccardi L, de Sio I, Terracciano F, Caturelli E, et al. Ablation treatment of primary and secondary liver tumors under contrast-enhanced ultrasound guidance in field practice of interventional ultrasound centers. A multicenter study. Eur J Radiol. 2018;105:96–101. [DOI] [PubMed]

16.

Francica G, Meloni MF, Riccardi L, Giangregorio F, Caturelli E, Terracciano F, et al. Role of Contrast-Enhanced Ultrasound in the Detection of Complications After Ultrasound-Guided Liver Interventional Procedures. J Ultrasound Med. 2021;40:1665–73. [DOI] [PubMed]

17.

Kaplan GG, Gregson DB, Laupland KB. Population-based study of the epidemiology of and the risk factors for pyogenic liver abscess. Clin Gastroenterol Hepatol. 2004;2:1032–8. [DOI] [PubMed]

18.

Meddings L, Myers RP, Hubbard J, Shaheen AA, Laupland KB, Dixon E, et al. A population-based study of pyogenic liver abscesses in the United States: incidence, mortality, and temporal trends. Am J Gastroenterol. 2010;105:117–24. [DOI] [PubMed]

19.

Pérez JAA, González JJ, Baldonedo RF, Sanz L, Carreño G, Junco A, et al. Clinical course, treatment, and multivariate analysis of risk factors for pyogenic liver abscess. Am J Surg. 2001;181:177–86. [DOI] [PubMed]

20.

Chou FF, Sheen-Chen SM, Chen YS, Chen MC. Single and multiple pyogenic liver abscesses: clinical course, etiology, and results of treatment. World J Surg. 1997;21:384–9. [DOI] [PubMed]

21.

Ogawa T, Shimizu S, Morisaki T, Sugitani A, Nakatsuka A, Mizumoto K, et al. The role of percutaneous transhepatic abscess drainage for liver abscess. J Hepatobiliary Pancreat Surg. 1999;6:263–6. [DOI] [PubMed]

22.

Ferraioli G, Garlaschelli A, Zanaboni D, Gulizia R, Brunetti E, Tinozzi FP, et al. Percutaneous and surgical treatment of pyogenic liver abscesses: observation over a 21-year period in 148 patients. Dig Liver Dis. 2008;40:690–6. [DOI] [PubMed]

23.

Mezhir JJ, Fong Y, Jacks LM, Getrajdman GI, Brody LA, Covey AM, et al. Current management of pyogenic liver abscess: surgery is now second-line treatment. J Am Coll Surg. 2010;210:975–83. [DOI] [PubMed]

24.

Giorgio A, Tarantino L, Mariniello N, Francica G, Scala E, Amoroso P, et al. Pyogenic liver abscesses: 13 years of experience in percutaneous needle aspiration with US guidance. Radiology. 1995;195:122–4. [DOI] [PubMed]

25.

Yu SCH, Ho SSM, Lau WY, Yeung DTK, Yuen EHY, Lee PSF, et al. Treatment of pyogenic liver abscess: prospective randomized comparison of catheter drainage and needle aspiration. Hepatology. 2004;39:932–8. [DOI] [PubMed]

26.

Lai K, Cheng K, Jeng L, Huang C, Lee Y, Chang H, et al. Factors associated with treatment failure of percutaneous catheter drainage for pyogenic liver abscess in patients with hepatobiliary-pancreatic cancer. Am J Surg. 2013;205:52–7. [DOI] [PubMed]

27.

Liao W, Tsai S, Yu C, Huang G, Lin Y, Hsu C, et al. Pyogenic liver abscess treated by percutaneous catheter drainage: MDCT measurement for treatment outcome. Eur J Radiol. 2012;81:609–15. [DOI] [PubMed]

28.

Du Z, Zhang L, Lu Q, Ren Y, Lv Y, Liu X, et al. Clinical Charateristics and Outcome of Pyogenic Liver Abscess with Different Size: 15-Year Experience from a Single Center. Sci Rep. 2016;6:35890. [DOI] [PubMed] [PMC]

29.

Lo JZW, Leow JJJ, Ng PLF, Lee HQ, Noor NAM, Low JK, et al. Predictors of therapy failure in a series of 741 adult pyogenic liver abscesses. J Hepatobiliary Pancreat Sci. 2015;22:156–65. [DOI] [PubMed]

30.

Xu S, Shi B, Chao L, Tan Y, Zhang X. Prognostic nomogram for the combination therapy of percutaneous catheter drainage and antibiotics in pyogenic liver abscess patients. Abdom Radiol (NY). 2020;45:393–402. [DOI] [PubMed]